856905-23-2 Usage
Uses
Used in Pharmaceutical Industry:
4-(oxazol-4-yl)benzoic acid is used as a pharmaceutical intermediate for the development of new drugs. Its potential biological and pharmacological properties make it a promising candidate for the treatment of various diseases.
Used in Organic Chemistry Research:
4-(oxazol-4-yl)benzoic acid is used as a research compound in organic chemistry. Its unique structure and properties allow scientists to study its reactions and interactions with other compounds, leading to the discovery of new chemical reactions and the development of novel synthetic methods.
Used in Drug Development:
4-(oxazol-4-yl)benzoic acid is used as a lead compound in drug development. Its potential anti-inflammatory, analgesic, and anti-cancer effects make it a valuable starting point for the design and synthesis of new therapeutic agents.
Used in Synthesis of New Materials:
4-(oxazol-4-yl)benzoic acid is used as a building block in the synthesis of new materials. Its chemical properties and reactivity make it a versatile component in the development of advanced materials with unique properties and applications.
Overall, 4-(oxazol-4-yl)benzoic acid is a versatile and promising compound with a diverse range of potential applications in various industries, including pharmaceuticals, organic chemistry research, drug development, and materials synthesis. Its unique structure and properties make it an attractive target for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 856905-23-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,6,9,0 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 856905-23:
(8*8)+(7*5)+(6*6)+(5*9)+(4*0)+(3*5)+(2*2)+(1*3)=202
202 % 10 = 2
So 856905-23-2 is a valid CAS Registry Number.
856905-23-2Relevant academic research and scientific papers
BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS
-
Page/Page column 19, (2010/02/12)
The present invention relates to novel benzazepine derivatives of structure (I) having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
